Aerie Pharmaceuticals Forecast and Stock Analysis
Technical AERI stock analysis for March 25, 2019.
Aerie Pharmaceuticals fell by -2.80% in the last day from $46.82 to $45.51 and has now fallen 3 days in a row. The price has fallen in 6 of the last 10 days and is down by -2.32% for this period. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -284 617 shares and in total 371 209 shares bought and sold for approximately $16.89 million.
Close price at the end of the last trading day (Monday, 25th Mar 2019) of the AERI stock was $45.51. This is 2.8% less than the trading day before Friday, 22nd Mar 2019.
During day the stock fluctuated 5.85% from a day low at $44.78 to a day high of $47.40.
30 day high of the AERI stock price was $50.10 and low was $39.50.
90 day high was $50.10 and low was $32.29.
52 week high for the Aerie Pharmaceuticals - $74.75 and low - $32.18.
Aerie Pharmaceuticals lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 19.96% during the next 3 months and, with 90% probability hold a price between $50.26 and $62.91 at the end of this period.
Aerie Pharmaceuticals holds a sales signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock. On further gains, the stock will meet resistance from the short-term moving average at approximately $46.74. On a fall, the stock will find some support from the long-term average at approximately $44.68. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sales signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sales signal was issued from a pivot top point on Thursday March 21, 2019, which indicates further falls until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
Relative Strength Index (RSI)
RSI14 is 46 and the stock is currently not being overbought or oversold
Support & Resistance
On the downside, the stock finds support just below today's level from accumulated volume at $40.30 and $40.18.
There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Aerie Pharmaceuticals finds support just below today's level at $40.30. If this is broken, then the next support from accumulated volume will be at $40.18 and $40.04.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $2.62 between high and low, or 5.85%. For the last week, the stock has had a daily average volatility of 5.90%.
Our recommended stoploss: $42.54 (-6.53%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from pivot top found 2 days ago.)
Very Low Low Medium High Very High
Evaluation: Buy Candidate
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term. We have upgraded our recommendation for this stock since last evaluation from a Hold/Accumulate to a Buy Candidate.